Pseudomonas aeruginosabiofilms in the respiratory tract of cystic fibrosis patients

…,CR Hansen, CB Andersen,TPressler… - Pediatric …, 2009 - Wiley Online Library
The present study was undertaken to investigate the appearance and location of Pseudomonas
aeruginosa in the cystic fibrosis (CF) lung and in sputum. Samples include preserved …

[HTML][HTML]Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis

P Garred,TPressler, HO Madsen… - The Journal of …, 1999 - Am Soc Clin Investig
Mannose-binding lectin (MBL) is a key factor in innate immunity, and lung infections are the
leading cause of morbidity and mortality in cystic fibrosis (CF). Accordingly, we investigated …

Rapid necrotic killing of polymorphonuclear leukocytes is caused by quorum-sensing-controlled production of rhamnolipid by Pseudomonas aeruginosa

…,C Moser,P Williams,TPressler… - …, 2007 - microbiologyresearch.org
Quorum sensing (QS) denotes a density-dependent mode of inter-bacterial communication
based on signal transmitter molecules. Active QS is present during chronic infections with the …

Occurrence of HypermutablePseudomonas aeruginosain Cystic Fibrosis Patients Is Associated with the Oxidative Stress Caused by Chronic Lung Inflammation

O Ciofu, B Riis,TPressler,HE Poulsen… - Antimicrobial agents …, 2005 - Am Soc Microbiol
Oxidative stress caused by chronic lung inflammation in patients with cystic fibrosis (CF)
and chronic lung infection with Pseudomonas aeruginosa is characterized by the reactive …

Cystic fibrosis–an example of personalized and precision medicine

M Skov,CR Hansen,TPressler- Apmis, 2019 - Wiley Online Library
Cystic fibrosis (CF) is a severe, monogenic, autosomal recessive disease caused by mutations
in the CFTR (cystic fibrosis transmembrane regulator) gene, where disturbed chloride …

Efficacy and safety of lumacaftor and ivacaftor in patients aged 6–11 years with cystic fibrosis homozygous for F508del-CFTR: a randomised, placebo-controlled …

…, S Junge, M Griese, D Staab,TPressler… - The Lancet Respiratory …, 2017 - Elsevier
Background Lumacaftor and ivacaftor combination treatment showed efficacy in patients
aged 12 years or older with cystic fibrosis homozygous for F508del-cystic fibrosis …

The immune response to chronicPseudomonas aeruginosalung infection in cystic fibrosis patients is predominantly of the Th2 type

C Moser, S Kjaergaard,TPressler, A Kharazmi… - Apmis, 2000 - Wiley Online Library
Most cystic fibrosis (CF) patients with chronic Pseudomonas aeruginosa lung infection have
a persistent acute type lung inflammation dominated by polymorphonuclear neutrophils (…

Aspergillus species and other molds in respiratory samples from patients with cystic fibrosis: a laboratory-based study with focus on Aspergillus fumigatus azole …

…, HK Johansen, M Skov,TPressler… - Journal of clinical …, 2011 - Am Soc Microbiol
Respiratory tract colonization by molds in patients with cystic fibrosis (CF) were analyzed,
with particular focus on the frequency, genotype, and underlying mechanism of azole …

[HTML][HTML]Spread of colistin resistant non-mucoid Pseudomonas aeruginosa among chronically infected Danish cystic fibrosis patients

HK Johansen, SM Moskowitz, O Ciofu,TPressler… - Journal of Cystic …, 2008 - Elsevier
Background Colistin resistant Pseudomonas aeruginosa have rarely been reported in cystic
fibrosis (CF) patients. Methods We performed a 17-year prospective study on colistin …

Effect of aerosolized rhDNase (Pulmozyme®) on pulmonary colonization in patients with cystic fibrosis

B Frederiksen,TPressler, A Hansen, C Koch… - Acta …, 2006 - Wiley Online Library
Background: Aerosolized recombinant human deoxyribonuclease (rhDNase I (Pulmozyme®))
has previously been shown to increase pulmonary function and reduce exacerbations of …